Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14 Teva Pharmaceutical is set to list its ordinary shares on Sept. 14. Barchart · Aug 2
This International Pharma Stock Just Hit 5-Year Highs Teva Pharmaceutical (TEVA) is trading at new 5-year highs. Shares are up more than 40% over the past year. The stock has strong technical momentum, maintaining a 100% “Buy” opinion from Barchart. TEVA offers international diversification and is favored by both Wall Street and individual investors. Today’s Featured Stock Valued... Barchart · Dec 26, 2025
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced new study findings based on newly established clinical thresholds on short-acting beta-agonist (SABA) use and real-world usage of ProAir Digihaler (albuterol sulfate) inhalation powder. ProAir Digihaler is a breath-actuated, digital SABA inhaler with built-in flow sensors that detect, record, and store objective data. 89% (319/359) of patients… Benzinga · May 17, 2022
Teva Pharmaceutical Industries: Why Investors Should Buy the Dip Shares of Teva Pharmaceutical (TEVA) have plunged in price due to the company’s weak financials and its reduction of its top-line guidance. However, can the stock rebound by the company leveraging its broad product and services portfolio? Read on. Let’s find out. StockNews.com · May 16, 2022